Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 15 | 2023 | 654 | 4.020 |
Why?
|
| Sleep Apnea, Obstructive | 8 | 2023 | 191 | 3.290 |
Why?
|
| Hypertension | 8 | 2024 | 1264 | 3.040 |
Why?
|
| Circadian Rhythm | 11 | 2016 | 268 | 2.190 |
Why?
|
| Myocytes, Cardiac | 11 | 2011 | 616 | 1.800 |
Why?
|
| Dysbiosis | 5 | 2023 | 115 | 1.690 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2023 | 71 | 1.270 |
Why?
|
| Circadian Clocks | 3 | 2016 | 60 | 1.220 |
Why?
|
| Probiotics | 2 | 2023 | 208 | 1.210 |
Why?
|
| Blood Pressure | 7 | 2024 | 1310 | 1.080 |
Why?
|
| Stroke | 4 | 2022 | 945 | 1.030 |
Why?
|
| Fecal Microbiota Transplantation | 4 | 2020 | 92 | 1.010 |
Why?
|
| Rats | 16 | 2023 | 3653 | 1.000 |
Why?
|
| Endothelin-1 | 2 | 2014 | 39 | 0.920 |
Why?
|
| Myocardium | 7 | 2011 | 982 | 0.890 |
Why?
|
| Metabolome | 2 | 2021 | 287 | 0.740 |
Why?
|
| Cerebrovascular Circulation | 2 | 2014 | 431 | 0.730 |
Why?
|
| Fasting | 2 | 2021 | 298 | 0.720 |
Why?
|
| Animals | 33 | 2023 | 33661 | 0.690 |
Why?
|
| Period Circadian Proteins | 3 | 2016 | 28 | 0.690 |
Why?
|
| Hypotension | 1 | 2021 | 175 | 0.660 |
Why?
|
| Microbiota | 1 | 2024 | 390 | 0.650 |
Why?
|
| Prebiotics | 1 | 2018 | 21 | 0.630 |
Why?
|
| Acetates | 1 | 2018 | 72 | 0.620 |
Why?
|
| Rats, Inbred WKY | 5 | 2022 | 54 | 0.610 |
Why?
|
| Sleep | 4 | 2015 | 336 | 0.610 |
Why?
|
| Rats, Inbred SHR | 5 | 2022 | 64 | 0.610 |
Why?
|
| Aging | 7 | 2022 | 1157 | 0.570 |
Why?
|
| Fatty Acids | 4 | 2009 | 337 | 0.530 |
Why?
|
| Gene Expression Regulation | 9 | 2011 | 2538 | 0.520 |
Why?
|
| Cerebral Arteries | 1 | 2016 | 79 | 0.500 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 9 | 0.490 |
Why?
|
| Heart | 4 | 2009 | 719 | 0.460 |
Why?
|
| Peroxynitrous Acid | 1 | 2013 | 7 | 0.440 |
Why?
|
| Disease Models, Animal | 8 | 2023 | 4273 | 0.440 |
Why?
|
| Rats, Long-Evans | 4 | 2018 | 102 | 0.440 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2011 | 353 | 0.430 |
Why?
|
| Microcirculation | 1 | 2013 | 94 | 0.430 |
Why?
|
| Biological Clocks | 2 | 2010 | 28 | 0.420 |
Why?
|
| Reperfusion Injury | 1 | 2013 | 103 | 0.410 |
Why?
|
| Myocardial Contraction | 3 | 2010 | 258 | 0.410 |
Why?
|
| CLOCK Proteins | 2 | 2011 | 28 | 0.400 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 147 | 0.370 |
Why?
|
| Brain Ischemia | 1 | 2013 | 257 | 0.360 |
Why?
|
| Fatty Acids, Volatile | 2 | 2020 | 32 | 0.360 |
Why?
|
| Signal Transduction | 3 | 2014 | 4505 | 0.360 |
Why?
|
| Cardiomegaly | 1 | 2011 | 136 | 0.350 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2009 | 65 | 0.340 |
Why?
|
| Glycoproteins | 1 | 2011 | 371 | 0.330 |
Why?
|
| Muscle Proteins | 2 | 2011 | 415 | 0.330 |
Why?
|
| Brain | 2 | 2020 | 2943 | 0.310 |
Why?
|
| Oleic Acid | 1 | 2007 | 15 | 0.290 |
Why?
|
| Rats, Wistar | 6 | 2008 | 356 | 0.280 |
Why?
|
| Vasoconstriction | 2 | 2019 | 103 | 0.270 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 2006 | 1 | 0.270 |
Why?
|
| Coenzyme A Ligases | 1 | 2006 | 6 | 0.270 |
Why?
|
| Cytosol | 1 | 2006 | 160 | 0.260 |
Why?
|
| ARNTL Transcription Factors | 3 | 2011 | 38 | 0.250 |
Why?
|
| Mice | 12 | 2023 | 17486 | 0.250 |
Why?
|
| Interleukin-17 | 2 | 2023 | 117 | 0.250 |
Why?
|
| Periodicity | 1 | 2005 | 56 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 261 | 0.240 |
Why?
|
| Time Factors | 6 | 2021 | 5994 | 0.240 |
Why?
|
| Germ-Free Life | 2 | 2021 | 60 | 0.230 |
Why?
|
| Male | 19 | 2023 | 59083 | 0.230 |
Why?
|
| Vasodilation | 2 | 2016 | 191 | 0.220 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 408 | 0.200 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 992 | 0.200 |
Why?
|
| Inflammation | 2 | 2020 | 1393 | 0.200 |
Why?
|
| Tryptophan | 1 | 2022 | 92 | 0.200 |
Why?
|
| Oleanolic Acid | 1 | 2021 | 7 | 0.190 |
Why?
|
| Cholic Acid | 1 | 2021 | 17 | 0.190 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 51 | 0.190 |
Why?
|
| Cecum | 1 | 2021 | 25 | 0.190 |
Why?
|
| Insulin | 1 | 2006 | 1190 | 0.180 |
Why?
|
| Feces | 3 | 2020 | 692 | 0.180 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 30 | 0.180 |
Why?
|
| Random Allocation | 1 | 2021 | 416 | 0.170 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 141 | 0.170 |
Why?
|
| Histamine | 1 | 2020 | 44 | 0.170 |
Why?
|
| Mast Cells | 1 | 2020 | 76 | 0.170 |
Why?
|
| Intestines | 2 | 2020 | 571 | 0.160 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 280 | 0.160 |
Why?
|
| Immune System | 1 | 2019 | 86 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 236 | 0.160 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2019 | 32 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 286 | 0.160 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2019 | 158 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 1809 | 0.150 |
Why?
|
| Recovery of Function | 2 | 2010 | 430 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 220 | 0.140 |
Why?
|
| Biodiversity | 1 | 2016 | 64 | 0.140 |
Why?
|
| Systole | 1 | 2016 | 197 | 0.140 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2015 | 10 | 0.130 |
Why?
|
| Energy Metabolism | 2 | 2011 | 737 | 0.130 |
Why?
|
| Cognition | 1 | 2020 | 726 | 0.130 |
Why?
|
| Triglycerides | 2 | 2009 | 556 | 0.130 |
Why?
|
| Pulmonary Artery | 1 | 2019 | 437 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 115 | 0.120 |
Why?
|
| Polysomnography | 1 | 2015 | 133 | 0.120 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 622 | 0.120 |
Why?
|
| Phylogeny | 1 | 2016 | 682 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 3069 | 0.110 |
Why?
|
| Purinergic P2Y Receptor Agonists | 1 | 2013 | 5 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 181 | 0.110 |
Why?
|
| Humans | 7 | 2024 | 121682 | 0.110 |
Why?
|
| Perfusion | 3 | 2009 | 192 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 813 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 512 | 0.100 |
Why?
|
| Middle Cerebral Artery | 1 | 2013 | 109 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1102 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 288 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 202 | 0.100 |
Why?
|
| Glucose | 2 | 2007 | 876 | 0.100 |
Why?
|
| Glycosylation | 1 | 2011 | 111 | 0.100 |
Why?
|
| Isoproterenol | 1 | 2011 | 105 | 0.090 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 1710 | 0.090 |
Why?
|
| Body Temperature | 1 | 2011 | 102 | 0.090 |
Why?
|
| Age Factors | 3 | 2020 | 2770 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2011 | 3763 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 4333 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 522 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.090 |
Why?
|
| Heart Rate | 2 | 2010 | 583 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2009 | 18 | 0.090 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2009 | 58 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1295 | 0.080 |
Why?
|
| Cardiotonic Agents | 1 | 2011 | 134 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 2038 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 389 | 0.080 |
Why?
|
| Wakefulness | 1 | 2009 | 98 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2007 | 971 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 507 | 0.070 |
Why?
|
| Regeneration | 1 | 2010 | 200 | 0.070 |
Why?
|
| Glycogenolysis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2009 | 2586 | 0.070 |
Why?
|
| Lactic Acid | 1 | 2007 | 145 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2007 | 380 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2007 | 302 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2007 | 442 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 1696 | 0.070 |
Why?
|
| Obesity | 1 | 2017 | 2082 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2439 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2009 | 1612 | 0.060 |
Why?
|
| PPAR alpha | 1 | 2006 | 54 | 0.060 |
Why?
|
| Uncoupling Protein 3 | 1 | 2005 | 5 | 0.060 |
Why?
|
| Sympathomimetics | 1 | 2005 | 10 | 0.060 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2005 | 21 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2006 | 221 | 0.060 |
Why?
|
| Norepinephrine | 1 | 2005 | 175 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2006 | 139 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2006 | 288 | 0.060 |
Why?
|
| Ion Channels | 1 | 2005 | 187 | 0.060 |
Why?
|
| Research Design | 1 | 2007 | 643 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2005 | 240 | 0.060 |
Why?
|
| Cytokines | 2 | 2020 | 1274 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2005 | 329 | 0.060 |
Why?
|
| Risk Factors | 1 | 2017 | 9668 | 0.050 |
Why?
|
| Models, Biological | 1 | 2008 | 1435 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1579 | 0.050 |
Why?
|
| RNA | 1 | 2006 | 578 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2005 | 392 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 660 | 0.050 |
Why?
|
| Bifidobacterium longum | 1 | 2020 | 3 | 0.040 |
Why?
|
| Clostridium symbiosum | 1 | 2020 | 3 | 0.040 |
Why?
|
| Faecalibacterium prausnitzii | 1 | 2020 | 4 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2020 | 5 | 0.040 |
Why?
|
| Mucin-4 | 1 | 2020 | 11 | 0.040 |
Why?
|
| Ileum | 1 | 2021 | 133 | 0.040 |
Why?
|
| Mucin-2 | 1 | 2020 | 35 | 0.040 |
Why?
|
| Environment | 1 | 2021 | 136 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2020 | 121 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2005 | 1022 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2020 | 195 | 0.040 |
Why?
|
| Leukocytes | 1 | 2020 | 209 | 0.040 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2019 | 39 | 0.040 |
Why?
|
| Phenylephrine | 1 | 2019 | 37 | 0.040 |
Why?
|
| Diet | 1 | 2006 | 1096 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 1281 | 0.040 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 52 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 212 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 138 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2018 | 196 | 0.040 |
Why?
|
| Muscle Strength | 1 | 2018 | 70 | 0.040 |
Why?
|
| Mutation | 1 | 2011 | 5738 | 0.040 |
Why?
|
| Memory | 1 | 2020 | 355 | 0.040 |
Why?
|
| Bacteria | 1 | 2020 | 473 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 368 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 499 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1094 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 23 | 0.030 |
Why?
|
| Biological Factors | 1 | 2013 | 29 | 0.030 |
Why?
|
| Respiration | 1 | 2013 | 123 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2013 | 221 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2009 | 1674 | 0.020 |
Why?
|
| Depression | 1 | 2020 | 1205 | 0.020 |
Why?
|
| Trachea | 1 | 2013 | 189 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2013 | 438 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1680 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1147 | 0.020 |
Why?
|
| Telemetry | 1 | 2007 | 27 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2007 | 62 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 97 | 0.020 |
Why?
|
| Genome | 1 | 2008 | 472 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 999 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2007 | 802 | 0.010 |
Why?
|
| Computational Biology | 1 | 2008 | 793 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2007 | 962 | 0.010 |
Why?
|
| Echocardiography | 1 | 2007 | 1065 | 0.010 |
Why?
|
| DNA | 1 | 2007 | 1608 | 0.010 |
Why?
|